Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Industry Trends 8
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 11
3 Market Snapshot 12
3.1 Market Definition - Infoholic Research 13
3.2 Total Addressable Market (TAM) 13
3.3 Segmented Addressable Market (SAM) 13
3.3.1 Difference between OTCs and prescription (Rx) medicines 14
3.3.2 Trends of over the counter drug market 14
3.4 Related Addressable Markets (RAM) 15
3.4.1 Oncology (Cancer) Drugs 15
3.4.2 Active pharmaceutical ingredients (APIs) 16
3.4.3 Diabetes Drugs Market 16
4 Market Outlook 18
4.1 Regulatory Scenario 18
4.1.1 US: 18
4.1.2 Europe: 18
4.1.3 Japan: 18
4.1.4 Turkey 19
4.2 Market Segmentation 20
4.3 Porter 5(Five) Forces 21
4.4 PEST Analysis 22
5 Market Characteristics 23
5.1 Market Dynamics 23
5.1.1 Drivers 23
5.1.1.1 Conducive government legislation 23
5.1.1.2 Switching of Rx drugs to OTC drugs 24
5.1.1.3 Cost-effective OTC drugs 24
5.1.2 Opportunities 25
5.1.2.1 A growing pain category 25
5.1.2.2 An increase in self-care 25
5.1.3 Restraints 25
5.1.3.1 Incorrect self-diagnosis 25
5.1.3.2 Side Effects and Misuse of Over the Counter Drugs 25
5.1.4 DRO - Impact Analysis 26
5.1.5 Key Stakeholders 27
6 Product Types: Market Size and Analysis 29
6.1 Overview 29
6.1.1 Cold' Cough and Allergy 30
6.1.2 Analgesics 31
6.1.3 Dermatology OTC Drugs 32
6.1.4 Gastrointestinal OTC Drugs 33
6.1.5 Ophthalmic OTC drugs 34
6.1.6 Vitamins and Minerals Supplements 35
6.1.7 Others 36
7 Regions: Market Size and Analysis 38
7.1 Overview 38
7.2 North America 39
7.2.1 Overview 39
7.3 Europe 40
7.3.1 Overview 40
7.4 APAC 42
7.4.1 Overview 42
7.5 Rest of the World 43
7.5.1 Overview 43
8 Competitive Landscape 45
9 Vendor Profiles 50
9.1 Sanofi 50
9.1.1 Overview 50
9.1.2 Geographic Revenue 53
9.1.3 Business Focus 53
9.1.4 SWOT Analysis 54
9.1.5 Business Strategy 54
9.2 Bayer AG 55
9.2.1 Overview 55
9.2.2 Business Unit 57
9.2.3 Geographic Presence 58
9.2.4 Business Focus 58
9.2.5 SWOT Analysis 59
9.2.6 Business Strategy 59
9.3 Johnson & Johnson 59
9.3.1 Overview 59
9.3.2 Business Units 63
9.3.3 Geographic Revenue 64
9.3.4 Business Focus 65
9.3.5 SWOT Analysis 66
9.3.6 Business Strategies 66
9.4 GlaxoSmithKline plc 67
9.4.1 Overview 67
9.4.2 Geographic Presence 71
9.4.3 Business Focus 71
9.4.4 SWOT Analysis 72
9.4.5 Business Strategy 72
10 Companies to Watch For 73
10.1 Pfizer Inc.' 73
10.1.1 Overview 73
10.1.2 Highlights 74
10.2 Synergy Pharmaceuticals Inc 74
10.2.1 Overview 74
10.2.2 Highlights 75
10.3 Innovus Pharmaceuticals 75
10.3.1 Overview 75
10.3.2 Highlights 75
10.4 Procter & Gamble Company 76
10.4.1 Overview 76
10.4.2 Highlights 76
10.5 Sun Pharmaceuticals. 77
10.5.1 Overview 77
10.5.2 Highlights 78
10.6 Merck & Co. 78
10.6.1 Overview 78
10.6.2 Highlights: 79
10.7 Takeda Pharmaceutical Co' Ltd 79
10.7.1 Overview 79
10.7.2 Highlights: 80
10.8 Boehringer Ingelheim GmbH 80
10.8.1 Overview 80
10.8.2 Highlights: 81
Annexure 82
Abbreviations 82

?